By otakuyassine3@gmail.com 
Sanctuary Advisors LLC lessened its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 9.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 3,156 shares of the company’s stock after selling 333 shares during the quarter. Sanctuary Advisors LLC’s holdings in Chemed were worth $1,802,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. EP Wealth Advisors LLC increased its position in shares of Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after buying an additional 25 shares during the period. Ballentine Partners LLC boosted its position in Chemed by 4.1% during the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after acquiring an additional 26 shares during the last quarter. Creative Planning grew its holdings in Chemed by 2.8% during the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after acquiring an additional 34 shares during the period. First Heartland Consultants Inc. grew its holdings in Chemed by 7.2% during the 3rd quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares during the period. Finally, First Trust Direct Indexing L.P. raised its position in shares of Chemed by 4.5% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock worth $533,000 after acquiring an additional 38 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.
Chemed Trading Up 0.6 %
Shares of NYSE CHE opened at $521.79 on Friday. The firm has a market capitalization of $7.85 billion, a P/E ratio of 26.37, a P/E/G ratio of 2.32 and a beta of 0.46. The firm’s 50-day moving average price is $565.72 and its 200-day moving average price is $564.07. Chemed Co. has a 1-year low of $516.91 and a 1-year high of $654.62.
Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $5.32 earnings per share. Equities research analysts forecast that Chemed Co. will post 21.43 EPS for the current year.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date was Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.
Wall Street Analyst Weigh In
CHE has been the topic of several research analyst reports. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.
Check Out Our Latest Stock Report on CHE
Insider Activity at Chemed
In related news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,132 shares of company stock valued at $3,003,502. 3.32% of the stock is owned by company insiders.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Chemed and related companies with MarketBeat.com’s FREE daily email newsletter.